Supernus Pharmaceuticals | SUPN - Ebit

Aktienkurs
49.43
Täglich Wechseln
-1.77 -3.46%
Monatlich
0.43%
Jährlich
47.86%
Q2 Prognose
48.44




Ebit Veränderung Datum
Abbott USD 1.85B 684M 2026-03
ANI Pharmaceuticals USD 38.71M 9.58M 2026-03
Aurora Cannabis CAD -35.79M 8.96M 2025-12
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Canopy Growth CAD -12.66M 1.64M 2025-12
Cara Therapeutics USD -5.94M 3.55M 2025-09
Corcept Therapeutics USD -49.6M 54.09M 2026-03
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Novo Nordisk DKK 59.62B 27.24B 2026-03
Pacira USD 4.62M 1.43M 2026-03
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD 4.99B 340M 2026-03
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
United Therapeutics USD 325.8M 340.4M 2026-03
Xeris Pharmaceuticals USD 16.77M 8.88M 2025-12